Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

AC Immune Q2 EPS $(0.21) Misses $(0.17) Estimate, Sales $1.54M Miss $1.98M Estimate

Author: Benzinga Newsdesk | August 05, 2025 07:25am
AC Immune (NASDAQ:ACIU) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.17) by 20.69 percent. This is a 16 percent increase over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $1.54 million which missed the analyst consensus estimate of $1.98 million by 22.13 percent. This is a 102.61 percent increase over sales of $759.59 thousand the same period last year.

Posted In: ACIU


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist